SBX-1052

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameSBX-1052
Drug Alias NameSBX-1052
ClassificationNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesStramsen Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesStramsen Biotech Inc
Inactive CompaniesN/A
Active IndicationsProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A